BIAF · NASDAQ
bioAffinity Technologies (BIAF) Stock Price & Fundamentals
bioAffinity Technologies (BIAF) closed at $763.58 on Oct 9, 2026, up 0.06% from the previous close of $763.11.
Share price, past year
1Y +25.80%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $763.58 |
| Sep 30, 2026 | $773.62 |
| Aug 31, 2026 | $732.15 |
| Jul 31, 2026 | $755.23 |
| Jun 30, 2026 | $706.45 |
| May 29, 2026 | $685.12 |
| Apr 30, 2026 | $654.38 |
| Mar 31, 2026 | $603.32 |
| Feb 27, 2026 | $593.42 |
| Jan 30, 2026 | $572.99 |
| Dec 31, 2025 | $565.33 |
| Nov 28, 2025 | $578.13 |
| Oct 31, 2025 | $606.98 |
Key statistics
- Market cap
- $5.18B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.24
- Revenue (TTM)
- $5.90M
- Net income (TTM)
- −$15.19M
- Shares outstanding
- 6.8M
- Dividend yield
- —
- 52-week range
- $546.26 – $790.13
bioAffinity Technologies's market cap is $5.18B, based on a share price of $763.58 and 6.8M shares outstanding as of Jun 30, 2026.
Financials
bioAffinity Technologies reported revenue of $6.16M for fiscal 2025, down 34.18% from fiscal 2024.
bioAffinity Technologies reported a net loss of $14.91M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $6.16M | −34.2% | −$14.91M | −242.0% | −$8.66 | −$9.39M |
| FY2024ended Dec 31, 2024 | $9.36M | +18.5% | −$9.04M | −96.6% | −$22.50 | −$7.34M |
| FY2023ended Dec 31, 2023 | $7.90M | +14.5% | −$7.94M | −100.5% | −$0.91 | −$6.06M |
| FY2022ended Dec 31, 2022 | $6.90M | — | −$8.15M | −118.2% | −$1.81 | −$4.29M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $1.51M | −$3.37M | −$0.64 |
| Q1 FY2026ended Mar 31, 2026 | $1.35M | −$3.63M | −$0.81 |
| Q4 FY2025ended Dec 31, 2025 | $1.59M | −$3.14M | $5.95 |
| Q3 FY2025ended Sep 30, 2025 | $1.45M | −$5.05M | −$4.74 |
| Q2 FY2025ended Jun 30, 2025 | $1.27M | −$4.06M | −$5.07 |
| Q1 FY2025ended Mar 31, 2025 | $1.85M | −$2.66M | −$4.80 |
| Q4 FY2024ended Dec 31, 2024 | $2.21M | −$2.97M | −$17.27 |
| Q3 FY2024ended Sep 30, 2024 | $2.35M | −$2.00M | −$4.84 |
Company profile
- Name
- bioAffinity Technologies, Inc.
- Ticker
- BIAF
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Services-Commercial Physical & Biological Research
- Headquarters
- 3300 Nacogdoches Road, Suite 216, San Antonio, TX 78217
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001712762
Recent SEC filings
- Oct 8, 2026
- Oct 6, 2026
- Sep 30, 2026
- Sep 22, 2026
- Sep 17, 2026
- Sep 11, 2026
- Sep 9, 2026
- Sep 3, 2026
Frequently asked questions
What is bioAffinity Technologies's stock price?
bioAffinity Technologies (BIAF) closed at $763.58 on Oct 9, 2026, up 0.06% from the previous close of $763.11.
What is bioAffinity Technologies's market cap?
bioAffinity Technologies's market cap is $5.18B, based on a share price of $763.58 and 6.8M shares outstanding as of Jun 30, 2026.
How much revenue does bioAffinity Technologies make?
bioAffinity Technologies reported revenue of $6.16M for fiscal 2025, down 34.18% from fiscal 2024.
Does bioAffinity Technologies pay a dividend?
bioAffinity Technologies's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from bioAffinity Technologies, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures